BR0109433A - Crystalline Pharmaceutical Substance - Google Patents

Crystalline Pharmaceutical Substance

Info

Publication number
BR0109433A
BR0109433A BR0109433-5A BR0109433A BR0109433A BR 0109433 A BR0109433 A BR 0109433A BR 0109433 A BR0109433 A BR 0109433A BR 0109433 A BR0109433 A BR 0109433A
Authority
BR
Brazil
Prior art keywords
pharmaceutical substance
crystalline pharmaceutical
crystalline
substance
crystaline
Prior art date
Application number
BR0109433-5A
Other languages
Portuguese (pt)
Inventor
Daniela A Dickman
Sanjay Chemburkar
James J Fort
Rodger F Henry
David Lechuga-Ballesteros
Yuping Niu
William Porter
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27065762&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR0109433(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US09/793,536 external-priority patent/US6608198B2/en
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of BR0109433A publication Critical patent/BR0109433A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/06—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D239/08—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms directly attached in position 2
    • C07D239/10—Oxygen or sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

"SUBSTâNCIA FARMACêUTICA CRISTALINA". Apresentam-se novas formas cristalinas de LOPINAVIR."CRYSTALINE PHARMACEUTICAL SUBSTANCE". New crystalline forms of LOPINAVIR are presented.

BR0109433-5A 2000-03-30 2001-03-21 Crystalline Pharmaceutical Substance BR0109433A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US53825700A 2000-03-30 2000-03-30
US09/793,536 US6608198B2 (en) 2000-03-30 2001-02-27 Crystalline pharmaceutical
PCT/US2001/009112 WO2001074787A2 (en) 2000-03-30 2001-03-21 Crystalline pharmaceutical

Publications (1)

Publication Number Publication Date
BR0109433A true BR0109433A (en) 2004-08-10

Family

ID=27065762

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0109433-5A BR0109433A (en) 2000-03-30 2001-03-21 Crystalline Pharmaceutical Substance

Country Status (22)

Country Link
EP (1) EP1268442A2 (en)
JP (1) JP2003529592A (en)
KR (1) KR100773258B1 (en)
CN (2) CN1330639C (en)
AR (2) AR033360A1 (en)
AU (3) AU2001250920B2 (en)
BG (1) BG107165A (en)
BR (1) BR0109433A (en)
CA (1) CA2403635A1 (en)
CZ (1) CZ20023529A3 (en)
HU (1) HUP0302675A3 (en)
IL (1) IL151551A0 (en)
MX (1) MXPA02009559A (en)
MY (1) MY128296A (en)
NO (1) NO325005B1 (en)
NZ (1) NZ521183A (en)
PE (1) PE20011232A1 (en)
PL (1) PL359727A1 (en)
SA (2) SA06270303B1 (en)
SK (1) SK14832002A3 (en)
TW (1) TWI284640B (en)
WO (1) WO2001074787A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6608198B2 (en) 2000-03-30 2003-08-19 Abbott Laboratories Crystalline pharmaceutical
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
WO2010089753A2 (en) * 2009-02-06 2010-08-12 Hetero Research Foundation Novel polymorphs of lopinavir
WO2011025849A1 (en) * 2009-08-27 2011-03-03 Merck Sharp & Dohme Corp. Processes for preparing protease inhibitors of hepatitis c virus
CN112830899A (en) * 2021-01-18 2021-05-25 合肥华方医药科技有限公司 Novel lopinavir crystal form and preparation method thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5914332A (en) * 1995-12-13 1999-06-22 Abbott Laboratories Retroviral protease inhibiting compounds
WO1998057648A1 (en) * 1997-06-16 1998-12-23 Vertex Pharmaceuticals Incorporated Methods of increasing the bioavailability of stable crystal polymorphs of a compound

Also Published As

Publication number Publication date
JP2003529592A (en) 2003-10-07
SA06270303B1 (en) 2009-08-02
TWI284640B (en) 2007-08-01
HUP0302675A2 (en) 2003-12-29
KR100773258B1 (en) 2007-11-05
KR20030011807A (en) 2003-02-11
WO2001074787A2 (en) 2001-10-11
NO20024679D0 (en) 2002-09-30
AU5092001A (en) 2001-10-15
NZ521183A (en) 2004-03-26
AU2001250920B2 (en) 2006-06-29
CN101066952A (en) 2007-11-07
PL359727A1 (en) 2004-09-06
WO2001074787A3 (en) 2002-02-07
NO325005B1 (en) 2008-01-14
AU2006222711A1 (en) 2006-10-19
AR049560A2 (en) 2006-08-16
SK14832002A3 (en) 2003-02-04
PE20011232A1 (en) 2001-12-08
MY128296A (en) 2007-01-31
AR033360A1 (en) 2003-12-17
CN1330639C (en) 2007-08-08
HUP0302675A3 (en) 2004-03-29
CA2403635A1 (en) 2001-10-11
IL151551A0 (en) 2003-04-10
EP1268442A2 (en) 2003-01-02
MXPA02009559A (en) 2003-05-21
SA01220270B1 (en) 2006-11-14
NO20024679L (en) 2002-09-30
CN1422259A (en) 2003-06-04
BG107165A (en) 2003-07-31
CZ20023529A3 (en) 2003-02-12

Similar Documents

Publication Publication Date Title
ATE296619T1 (en) SOLID ORAL DOSAGE FORM OF SIMETHICON
PT1207867E (en) FORMS OF DELAYED PHARMACEUTICAL ADMINISTRATION CONTAINING TRAMADOL
CY2014003I2 (en) PHARMACEUTICAL FORMS OF Echinocandin CONTAINING MICCULE FORMING SURFACTANTS
PT1253932E (en) PHARMACEUTICAL COMPOUNDS OF BOTULINIC TOXIN
EA199900373A2 (en) PHARMACEUTICAL COMPOSITIONS
DE60142473D1 (en) INTRAKORPORAL MEDICAMENTS FOR THE PHOTODYNAMIC TREATMENT OF ILLNESSES
PT1193270E (en) PYRROLOBENZODIAZEPINAS
PT956858E (en) PHARMACEUTICAL COMPOSITIONS CONTAINING LACTOBACILS FOR THE TREATMENT OF VAGINAL INFECTIONS
NO20042842L (en) Pharmaceutical formulations of platinum derivative
UY27175A1 (en) NEW SUCCINATE SALT OF O-DESMETIL- VENLAFAXINA
PT1242425E (en) COMPOUNDS OF N - (5,7-DIMETOXY-1,2,4 | TRIAZOLO1,5-A | PYRIMIDIN-2-YL) ARYLSULPHONAMIDE AND ITS USE AS HERBICIDES
NO20052794L (en) Antibacterial indoloxazolidinone intermediates for their preparation and pharmaceutical preparations containing them
DE60132600D1 (en) MEDICAMENTS FOR THE CHEMOTHERAPEUTIC TREATMENT OF ILLNESSES
NO20055010D0 (en) Preparations containing lactulose for the treatment of potavirus infections
EE05020B1 (en) The pharmaceutical composition of G1buride
SE9901077D0 (en) Novel use
DE60036093D1 (en) ANTAGONISTS OF GARDOS CANAL
BR0114379A (en) Substituted c-cyclohexylmethylamine derivatives
DE50013843D1 (en) MEDICAMENT FOR THE TREATMENT OF DARMER DISEASES
SE9801494D0 (en) Novel use
CO4940448A1 (en) GLASS MODIFICATION OF A MEDICINAL SUBSTANCE
ATE312104T1 (en) COMPOUNDS FOR THE TREATMENT OF IMPAIRED FUNDIC RELAXATION
TR200402230T4 (en) O-substituted 6-methyl-tramadol derivatives
BR0109433A (en) Crystalline Pharmaceutical Substance
BR0011300A (en) Crystalline forms of a macrolide antibiotic

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8O, 11, 13, 24 E 25 DA LPI

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.